Cargando…

From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy

Genome-wide association studies have proven to be highly effective at defining relationships between single nucleotide polymorphisms (SNPs) and clinical phenotypes in complex diseases. Establishing a mechanistic link between a noncoding SNP and the clinical outcome is a significant hurdle in transla...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Sebastian, Nair, Viji, Patel, Sanjeevkumar R., Eichinger, Felix, Nelson, Robert G., Weil, E. Jennifer, Pezzolesi, Marcus G., Krolewski, Andrzej S., Randolph, Ann, Keller, Benjamin J., Werner, Thomas, Kretzler, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712052/
https://www.ncbi.nlm.nih.gov/pubmed/23434934
http://dx.doi.org/10.2337/db12-1416
_version_ 1782277010249220096
author Martini, Sebastian
Nair, Viji
Patel, Sanjeevkumar R.
Eichinger, Felix
Nelson, Robert G.
Weil, E. Jennifer
Pezzolesi, Marcus G.
Krolewski, Andrzej S.
Randolph, Ann
Keller, Benjamin J.
Werner, Thomas
Kretzler, Matthias
author_facet Martini, Sebastian
Nair, Viji
Patel, Sanjeevkumar R.
Eichinger, Felix
Nelson, Robert G.
Weil, E. Jennifer
Pezzolesi, Marcus G.
Krolewski, Andrzej S.
Randolph, Ann
Keller, Benjamin J.
Werner, Thomas
Kretzler, Matthias
author_sort Martini, Sebastian
collection PubMed
description Genome-wide association studies have proven to be highly effective at defining relationships between single nucleotide polymorphisms (SNPs) and clinical phenotypes in complex diseases. Establishing a mechanistic link between a noncoding SNP and the clinical outcome is a significant hurdle in translating associations into biological insight. We demonstrate an approach to assess the functional context of a diabetic nephropathy (DN)-associated SNP located in the promoter region of the gene FRMD3. The approach integrates pathway analyses with transcriptional regulatory pattern-based promoter modeling and allows the identification of a transcriptional framework affected by the DN-associated SNP in the FRMD3 promoter. This framework provides a testable hypothesis for mechanisms of genomic variation and transcriptional regulation in the context of DN. Our model proposes a possible transcriptional link through which the polymorphism in the FRMD3 promoter could influence transcriptional regulation within the bone morphogenetic protein (BMP)-signaling pathway. These findings provide the rationale to interrogate the biological link between FRMD3 and the BMP pathway and serve as an example of functional genomics-based hypothesis generation.
format Online
Article
Text
id pubmed-3712052
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-37120522014-07-01 From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy Martini, Sebastian Nair, Viji Patel, Sanjeevkumar R. Eichinger, Felix Nelson, Robert G. Weil, E. Jennifer Pezzolesi, Marcus G. Krolewski, Andrzej S. Randolph, Ann Keller, Benjamin J. Werner, Thomas Kretzler, Matthias Diabetes Original Research Genome-wide association studies have proven to be highly effective at defining relationships between single nucleotide polymorphisms (SNPs) and clinical phenotypes in complex diseases. Establishing a mechanistic link between a noncoding SNP and the clinical outcome is a significant hurdle in translating associations into biological insight. We demonstrate an approach to assess the functional context of a diabetic nephropathy (DN)-associated SNP located in the promoter region of the gene FRMD3. The approach integrates pathway analyses with transcriptional regulatory pattern-based promoter modeling and allows the identification of a transcriptional framework affected by the DN-associated SNP in the FRMD3 promoter. This framework provides a testable hypothesis for mechanisms of genomic variation and transcriptional regulation in the context of DN. Our model proposes a possible transcriptional link through which the polymorphism in the FRMD3 promoter could influence transcriptional regulation within the bone morphogenetic protein (BMP)-signaling pathway. These findings provide the rationale to interrogate the biological link between FRMD3 and the BMP pathway and serve as an example of functional genomics-based hypothesis generation. American Diabetes Association 2013-07 2013-06-14 /pmc/articles/PMC3712052/ /pubmed/23434934 http://dx.doi.org/10.2337/db12-1416 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Martini, Sebastian
Nair, Viji
Patel, Sanjeevkumar R.
Eichinger, Felix
Nelson, Robert G.
Weil, E. Jennifer
Pezzolesi, Marcus G.
Krolewski, Andrzej S.
Randolph, Ann
Keller, Benjamin J.
Werner, Thomas
Kretzler, Matthias
From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
title From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
title_full From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
title_fullStr From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
title_full_unstemmed From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
title_short From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
title_sort from single nucleotide polymorphism to transcriptional mechanism: a model for frmd3 in diabetic nephropathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712052/
https://www.ncbi.nlm.nih.gov/pubmed/23434934
http://dx.doi.org/10.2337/db12-1416
work_keys_str_mv AT martinisebastian fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT nairviji fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT patelsanjeevkumarr fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT eichingerfelix fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT nelsonrobertg fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT weilejennifer fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT pezzolesimarcusg fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT krolewskiandrzejs fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT randolphann fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT kellerbenjaminj fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT wernerthomas fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy
AT kretzlermatthias fromsinglenucleotidepolymorphismtotranscriptionalmechanismamodelforfrmd3indiabeticnephropathy